- Home
- ORIC vs DHC Comparison
ORIC vs DHC Comparison
Compare ORIC & DHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- DHC
- Stock Information
- Founded
- ORIC 2014
- DHC 1998
- Country
- ORIC United States
- DHC United States
- Employees
- ORIC N/A
- DHC N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- DHC Real Estate Investment Trusts
- Sector
- ORIC Health Care
- DHC Real Estate
- Exchange
- ORIC Nasdaq
- DHC Nasdaq
- Market Cap
- ORIC 633.7M
- DHC 629.7M
- IPO Year
- ORIC 2020
- DHC N/A
- Fundamental
- Price
- ORIC $10.33
- DHC $2.18
- Analyst Decision
- ORIC Strong Buy
- DHC Hold
- Analyst Count
- ORIC 9
- DHC 3
- Target Price
- ORIC $18.75
- DHC $4.50
- AVG Volume (30 Days)
- ORIC 584.3K
- DHC 915.2K
- Earning Date
- ORIC 03-10-2025
- DHC 02-24-2025
- Dividend Yield
- ORIC N/A
- DHC 1.83%
- EPS Growth
- ORIC N/A
- DHC N/A
- EPS
- ORIC N/A
- DHC N/A
- Revenue
- ORIC N/A
- DHC $1,477,343,000.00
- Revenue This Year
- ORIC N/A
- DHC N/A
- Revenue Next Year
- ORIC N/A
- DHC $4.46
- P/E Ratio
- ORIC N/A
- DHC N/A
- Revenue Growth
- ORIC N/A
- DHC 6.62
- 52 Week Low
- ORIC $6.33
- DHC $2.01
- 52 Week High
- ORIC $16.65
- DHC $4.24
- Technical
- Relative Strength Index (RSI)
- ORIC 59.58
- DHC 45.80
- Support Level
- ORIC $9.69
- DHC $2.03
- Resistance Level
- ORIC $11.15
- DHC $2.14
- Average True Range (ATR)
- ORIC 0.82
- DHC 0.09
- MACD
- ORIC 0.18
- DHC 0.02
- Stochastic Oscillator
- ORIC 75.08
- DHC 50.00
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.
About DHC Diversified Healthcare Trust of Beneficial Interest
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs.